- Presentations
- 4
- Markets
- 1
Synjardy is a brand of Empagliflozin and Metformin marketed by Boehringer Ingelheim Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Empagliflozin and Metformin
- Brand owner
- Boehringer Ingelheim Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 12.5 mg/1000 mg tablet, 12.5 mg/500 mg tablet, 5 mg/1000 mg tablet, 5 mg/500 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Synjardy 12.5 mg/1000 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Synjardy 12.5 mg/500 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Synjardy 5 mg/1000 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Synjardy 5 mg/500 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Empagliflozin and Metformin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Synjardy
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.